Median OS was @ months in the motesanib plus C/P arm and @ months in the placebo plus C/P arm ( P = @ ) ; median PFS was @ and @ months , respectively , ( P = @ ) ; and ORR was @ % and @ % , respectively , ( P < @ ) .